The Indus Water Treaty (IWT) is a water-sharing agreement between India and Pakistan with the World Bank being a signatory of the pact which was signed in 1960. The treaty set out a mechanism for ...

Till now, India has been using limited water from Chenab, mostly for irrigation, but by putting the treaty in abeyance, there is scope for expanding its use. The government is considering plans to ...

NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has successfully closed the acquisition of its external manager, RP Management, LLC ("RP Management ...

New Delhi “put in abeyance” its participation in the Indus Waters Treaty (IWT) of 1960, which governs usage of the Indus river system, shortly after 26 civilians in Indian Kashmir were killed ...

Modi said in a fiery speech that 'water and blood cannot flow together'. Jal Shakti minister CR Paatil told a media that his ministry would implement what Prime Minister Modi says and 'try to ...

India has no plans to hold talks with Pakistani authorities on the Indus Waters Treaty, which will remain suspended, two people familiar with the matter said. India has no plans to hold talks with ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against ...

Amidst rising tensions with Pakistan and the suspension of the Indus Waters Treaty, India has opened two gates of the Baglihar Dam on the Chenab River. This action, following a prior restriction ...

After President Donald Trump signed a sweeping executive order aimed at cutting the cost of prescription drugs in the U.S., New Jersey’s pharmaceutical industry is speaking out about the plan.

The Nifty Pharma index was the only sectoral index that opened in the red, amid an across-the-board rally. Pharma stocks, however, recovered lost ground, and the Nifty Pharma closed marginally ...

He said he expects the order will reduce the cost of pharmaceuticals by 30% to 80%. "Our Country will finally be treated fairly, and our citizens [sic] Healthcare Costs will be reduced by numbers ...

(Reuters) -Bain Capital is in talks to buy contract drug manufacturer PCI Pharma Services at a valuation of $10 billion, Bloomberg News reported on Friday, citing people familiar with the matter.